RUZZI, FRANCESCA
 Distribuzione geografica
Continente #
EU - Europa 519
NA - Nord America 433
AS - Asia 284
AF - Africa 28
OC - Oceania 1
Totale 1.265
Nazione #
US - Stati Uniti d'America 432
IT - Italia 266
CN - Cina 177
DE - Germania 79
VN - Vietnam 73
SE - Svezia 41
GB - Regno Unito 33
CH - Svizzera 24
IE - Irlanda 19
FR - Francia 16
IN - India 16
RU - Federazione Russa 11
BG - Bulgaria 10
CI - Costa d'Avorio 10
TG - Togo 9
JO - Giordania 6
HK - Hong Kong 5
FI - Finlandia 4
RO - Romania 4
DK - Danimarca 3
EG - Egitto 3
HR - Croazia 3
NL - Olanda 3
SG - Singapore 3
ZA - Sudafrica 3
AT - Austria 2
NG - Nigeria 2
TR - Turchia 2
AU - Australia 1
BE - Belgio 1
CA - Canada 1
JP - Giappone 1
PK - Pakistan 1
SN - Senegal 1
Totale 1.265
Città #
Shanghai 164
Bologna 62
Chandler 57
Fairfield 47
Dong Ket 44
Ashburn 39
Ann Arbor 37
Frankfurt am Main 33
Houston 31
Woodbridge 27
Southend 25
Bern 24
Dublin 19
Milan 18
Seattle 17
Cambridge 14
Wilmington 13
Princeton 12
Abidjan 10
Sofia 10
Turin 10
Lomé 9
Bremen 8
Redmond 8
Kerpen 7
Amman 6
Crocetta 6
Moscow 6
Naples 6
New York 6
Rome 6
Beijing 5
Bo 5
Delhi 5
Vicenza 5
Council Bluffs 4
Hong Kong 4
Los Angeles 4
Reggio Nell'emilia 4
Berlin 3
Carrara 3
Castenaso 3
Des Moines 3
Mülheim 3
Nærum 3
Portici 3
Singapore 3
Abeokuta 2
Amsterdam 2
Ankara 2
Boydton 2
Bühl 2
Catanzaro 2
Changsha 2
Chieti 2
Civate 2
Crotone 2
Dallas 2
Florence 2
Fusignano 2
Giavera del Montello 2
Guangzhou 2
Lappeenranta 2
Parma 2
Pescara 2
Romainville 2
San Benedetto del Tronto 2
San Diego 2
San Giorgio di Piano 2
Vedelago 2
Vienna 2
Westminster 2
Alfortville 1
Boardman 1
Bruges 1
Candiolo 1
Cavenago Di Brianza 1
Cordenons 1
Correggio 1
Costa Volpino 1
Cupertino 1
Falkenstein 1
Hebei 1
Helsinki 1
Hounslow 1
Islamabad 1
Jiaxing 1
Kagoya 1
London 1
Medford 1
Montelupone 1
Montescudo 1
Muizenberg 1
Nanjing 1
Orzinuovi 1
Paris 1
Pesaro 1
Phoenix 1
Redwood City 1
Reggio Emilia 1
Totale 919
Nome #
IFN-γ and CD38 in Hyperprogressive Cancer Development 279
Early stability and late random tumor progression of a HER2-positive primary breast cancer patient-derived xenograft 223
Bone sarcoma patient-derived xenografts are faithful and stable preclinical models for molecular and therapeutic investigations 208
Cancer Vaccines Co-Targeting HER2/Neu and IGF1R 163
Integrated molecular characterization of patient-derived models reveals therapeutic strategies for treating CIC-DUX4 sarcoma 151
Evolution of HER2-positive mammary carcinoma: HER2 loss reveals claudin-low traits in cancer progression 70
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 68
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy 44
Synovial Sarcoma Preclinical Modeling: Integrating Transgenic Mouse Models and Patient-Derived Models for Translational Research 42
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine 39
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality 35
IL-1 Family Members in Bone Sarcomas 14
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis 7
Totale 1.343
Categoria #
all - tutte 3.496
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.496


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20194 0 0 0 0 0 0 0 0 0 0 4 0
2019/202090 4 2 2 9 17 8 8 11 11 10 6 2
2020/2021282 10 1 2 12 11 4 26 77 20 15 9 95
2021/2022235 11 13 11 8 21 27 7 22 30 28 35 22
2022/2023373 23 32 20 51 26 32 19 15 52 17 46 40
2023/2024357 16 9 31 27 25 25 17 186 9 12 0 0
Totale 1.343